Company Filing History:
Years Active: 2022-2024
Title: Laura Lauener: Innovator in Immunoconjugates
Introduction
Laura Lauener is a prominent inventor based in Schlieren, Switzerland. She has made significant contributions to the field of immunoconjugates, with a focus on developing innovative therapeutic solutions. Her work has led to the filing of 2 patents that showcase her expertise and dedication to advancing medical science.
Latest Patents
Laura's latest patents revolve around immunoconjugates, particularly those comprising a mutant interleukin-2 polypeptide and an antibody that binds to PD-1. These inventions include polynucleotide molecules encoding the immunoconjugates, as well as vectors and host cells that incorporate such polynucleotide molecules. Furthermore, her patents detail methods for producing the mutant immunoconjugates, pharmaceutical compositions that include them, and various uses of these innovative compounds.
Career Highlights
Throughout her career, Laura has worked with notable companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research and development.
Collaborations
Laura has had the opportunity to work alongside talented individuals, including Laura Codarri Deak and Christian Klein. These collaborations have enriched her professional journey and fostered an environment of innovation and creativity.
Conclusion
Laura Lauener's contributions to the field of immunoconjugates exemplify her commitment to advancing medical research and developing new therapeutic options. Her innovative patents and collaborations highlight her role as a key player in the scientific community.